GO:0045901 positive regulation of translational elongation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045901 describes any process that activates or increases the frequency, rate or extent of translational elongation, the stage of protein synthesis in which amino acids are added to a growing polypeptide chain.
• Translational elongation is a major regulatory hub: its positive control determines how efficiently mRNAs are decoded and is frequently rewired in cancer and immune exhaustion.
• Key positive regulators include translation elongation factors (eEF1A, eEF2), mTORC1-dependent signaling, and RNA-binding proteins that relieve elongation pausing.
• Dysregulated positive regulation of translational elongation is linked to prostate cancer anaplastic subtypes, T cell exhaustion, and epithelial-mesenchymal transition.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of elongation regulators in disease-relevant cell types.
• Ribo-seq, polysome profiling and proteomics are the primary methods to quantify elongation rates and identify the genes that control them.
Description
Positive regulation of translational elongation (GO:0045901) is the biological process that activates or increases the frequency, rate or extent of translational elongation, the cyclical addition of amino acids to a nascent polypeptide on the ribosome. Because elongation consumes most of the energy devoted to protein synthesis and sets the pace of proteome remodeling, its positive control is a central determinant of cell growth, differentiation and stress responses. Researchers study GO:0045901 to understand how cells tune protein output without changing mRNA levels, and to identify therapeutic entry points in diseases where translation is hyperactivated or misregulated. The term is defined in QuickGO as any process that activates or increases the frequency, rate or extent of translational elongation, and it is classified under biological_process. Its synonyms include activation of translational elongation, stimulation of translational elongation, up regulation of translational elongation, up-regulation of translational elongation and upregulation of translational elongation. In practice, positive regulation of translational elongation is executed by elongation factors, signaling kinases and RNA-binding proteins that relieve ribosome pausing and accelerate codon decoding. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanism, key genes, disease links and experimental models for GO:0045901.
positive regulation of translational elongation At A Glance
| GO ID | GO:0045901 |
|---|---|
| GO term | positive regulation of translational elongation |
| Ontology | biological_process |
| Synonym | activation of translational elongation; stimulation of translational elongation; up regulation of translational elongation; up-regulation of translational elongation; upregulation of translational elongation |
| Major function | Increases the frequency, rate or extent of translational elongation during protein synthesis |
| Biological context | Protein synthesis control, cell growth, immune quiescence and cancer progression |
| Key regulators | Translation elongation factors, mTORC1 signaling, RNA-binding proteins such as hnRNP E1 |
| Disease relevance | Prostate cancer anaplastic subtype, T cell exhaustion, epithelial-mesenchymal transition |
What Is GO:0045901?
In plain terms, GO:0045901 covers every cellular activity that speeds up or enhances the elongation phase of translation, the step where the ribosome reads codons and adds amino acids to a growing protein chain. It does not describe the initiation or termination phases; it specifically captures positive control of elongation rate, frequency or extent. This regulation can be exerted by translation elongation factors, by signaling pathways that modify them, or by RNA elements and RNA-binding proteins that alter ribosome transit.
Why Is positive regulation of translational elongation Important in Cell Biology?
Positive regulation of translational elongation is important because it allows cells to rapidly change protein output in response to growth signals, stress and immune cues without waiting for new transcription. In cancer, enhanced elongation supports the high biosynthetic demand of tumor cells, and in T cells it contributes to quiescence and exhaustion programs. Understanding GO:0045901 therefore informs both basic mechanisms of gene expression and therapeutic strategies that target translation.
• Controls the rate of protein synthesis, a major determinant of cell growth and proliferation.
• Enables rapid proteome remodeling during immune activation and exhaustion.
• Is frequently hyperactivated in aggressive cancers such as anaplastic prostate cancer.
• Contributes to epithelial-mesenchymal transition and metastasis programs.
• Provides targets for therapies that inhibit translation elongation in tumors.
• Integrates nutrient and growth-factor signals via mTORC1 and related pathways.
• Affects mRNA stability and codon optimality through ribosome transit.
• Is studied with Ribo-seq and polysome profiling to quantify elongation in vivo.
• Links RNA modifications and transcription elongation to translation output.
• Offers CRISPR-based causal validation of candidate elongation regulators.
What Happens During positive regulation of translational elongation?
Ribosome decoding and factor recruitment
In simple terms: The ribosome reads the mRNA and elongation factors help it move forward faster.
During elongation, aminoacyl-tRNAs deliver amino acids to the ribosomal A site, and elongation factors such as eEF1A and eEF2 promote codon recognition and translocation. Positive regulation of translational elongation increases the frequency or rate of these steps, often by elevating factor availability or activity. In cancer cells, this acceleration supports the high protein output needed for proliferation.
Signaling inputs that stimulate elongation
In simple terms: Growth signals tell the translation machinery to speed up.
mTORC1 and related nutrient-sensing pathways phosphorylate elongation regulators and thereby increase elongation rates. This signaling couples environmental cues to protein synthesis, and its dysregulation is a hallmark of tumors with enhanced translational capacity. Positive regulation of translational elongation is therefore a downstream effector of oncogenic signaling.
RNA-binding proteins and pausing relief
In simple terms: RNA-binding proteins can remove roadblocks that slow the ribosome.
hnRNP E1 regulates translational elongation in the context of epithelial-mesenchymal transition, illustrating how RNA-binding proteins control elongation. Relief of ribosome pausing by such factors is a mechanism of positive regulation of translational elongation. This layer of control allows transcript-specific tuning of protein output.
Coupling to transcription and RNA modification
In simple terms: Changes in RNA processing can feed into faster translation.
Pseudouridylation of 7SK by PUS7 regulates Pol II transcription elongation, showing cross-talk between transcription elongation and downstream translation control. LINE1 splicing variants regulate T cell quiescence and exhaustion, linking RNA processing to translational programs. These examples show that positive regulation of translational elongation is embedded in broader RNA regulatory networks.
Key Genes Involved in GO:0045901 positive regulation of translational elongation
The following genes and proteins are experimentally implicated in positive regulation of translational elongation or in its disease-relevant control.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EEF1A1 | Delivers aminoacyl-tRNA to the ribosome A site during elongation | Core elongation factor; target for translation inhibition studies |
| EEF2 | Catalyzes ribosomal translocation during elongation | Rate-limiting elongation factor; linked to translation control |
| MTOR | Kinase that stimulates translation elongation via downstream effectors | Central positive regulator of protein synthesis |
| RPTOR | Component of mTORC1 that promotes elongation | Nutrient-sensitive control of translation |
| EIF4EBP1 | Repressor of translation initiation; its inhibition indirectly supports elongation | Marker of mTORC1 activity |
| RPS6KB1 | mTORC1 substrate that promotes translation | Readout of active translation signaling |
| HNRNPE1 | RNA-binding protein regulating translational elongation in EMT | Context-specific elongation regulator |
| PUS7 | Pseudouridylates 7SK and regulates Pol II transcription elongation | Links RNA modification to elongation control |
| LINE1 | Spliced variants regulate T cell quiescence and exhaustion | Immune translational regulation |
| SP1 | Transcription factor associated with anaplastic prostate cancer and translation elongation targeting | Therapeutic target in aggressive prostate cancer |
| CDF1 | Photoperiodic regulator of hypocotyl elongation in plants | Plant elongation control model |
| CDF5 | Photoperiodic regulator of hypocotyl elongation in plants | Plant elongation control model |
| DIVIVA | Bacterial cell division protein with roles in elongation | Bacterial morphogenesis model |
| GCN2 | Stress kinase that modulates translation in response to amino acid limitation | Integrated stress response control |
| EIF2AK1 | Heme-regulated kinase that can influence translation | Stress-responsive translation control |
| EIF4E | Cap-binding factor influencing translation efficiency | Translation output readout |
| RPL/RPS genes | Ribosomal proteins required for elongation | Ribosomopathy and translation studies |
How Is positive regulation of translational elongation Regulated?
Positive regulation of translational elongation is controlled by nutrient and growth-factor signaling, most prominently mTORC1, which phosphorylates effectors that enhance elongation. RNA-binding proteins such as hnRNP E1 can relieve pausing and stimulate elongation in specific contexts. RNA modifications and transcription elongation factors, including PUS7-dependent pseudouridylation of 7SK, can also influence the translational program. In immune cells, LINE1 splicing variants regulate quiescence and exhaustion, adding a layer of cell-state control.
positive regulation of translational elongation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SP1 | Anaplastic prostate cancer | CRISPR knockout in prostate cancer cell lines |
| EEF1A1 | Cancer translation dependency | Point-mutation and overexpression models |
| EEF2 | Translation elongation in tumors | Knock-in of phospho-mimetic variants |
| HNRNPE1 | Epithelial-mesenchymal transition | Knockout and rescue in epithelial cells |
| LINE1 | T cell exhaustion | Knockout in primary T cells |
Cancer: anaplastic prostate cancer and translation elongation
An anaplastic subtype of prostate cancer has been identified that is amenable to therapies targeting SP1 or translation elongation, directly linking GO:0045901 to a lethal tumor phenotype. Enhanced elongation supports the biosynthetic demands of these tumors, and targeting elongation factors or their regulators is a candidate therapeutic strategy.
Immune exhaustion and T cell quiescence
LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion, implicating translational control in immune cell states. Positive regulation of translational elongation contributes to the protein synthesis programs that accompany these transitions.
Epithelial-mesenchymal transition and metastasis
hnRNP E1 sits at the crossroads of translational regulation of epithelial-mesenchymal transition, a process central to metastasis. Its control of elongation influences the proteome changes required for cells to acquire migratory and invasive properties.
From positive regulation of translational elongation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an elongation factor reduce translation rate? | CRISPR knockout cell line |
| Does a specific phosphorylation site control elongation? | Point-mutation knock-in |
| Can a tagged factor be used to measure ribosome association? | Tagged knock-in |
| Does overexpression of a regulator increase protein synthesis? | Overexpression cell model |
| Which transcripts depend on a given elongation regulator? | Ribo-seq after knockout |
| Does a candidate gene causally drive tumor growth? | Xenograft with CRISPR-edited cells |
How to Study the positive regulation of translational elongation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and elongation rate | Transcript-specific elongation control |
| Polysome profiling | mRNA distribution across ribosomes | Global translation efficiency |
| Puromycin incorporation | Newly synthesized protein | Validation of elongation changes |
| Mass spectrometry | Proteome changes | Protein output after perturbation |
| RNA-seq | Transcript abundance | Distinguishing transcription from translation |
| Western blot | Protein levels of elongation factors | Target validation |
| Immunofluorescence | Localization of translation machinery | Single-cell translation imaging |
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy across the transcriptome and can infer elongation rates and pausing. It is used to identify transcripts whose translation depends on a candidate positive regulator of translational elongation.
Polysome profiling
Polysome profiling separates mRNAs by the number of bound ribosomes, providing a global readout of translation efficiency. It is commonly paired with knockout or overexpression of elongation regulators.
Proteomics and puromycin incorporation
Puromycin incorporation and mass spectrometry quantify newly synthesized proteins, directly reflecting elongation activity. These methods validate whether a genetic perturbation changes protein output.
Imaging and reporter assays
Fluorescent reporters and live-cell imaging can track translation in single cells and reveal heterogeneity in elongation control. They are useful for linking GO:0045901 to cell-state transitions such as exhaustion.
How CRISPR Can Be Used to Study GO:0045901 positive regulation of translational elongation
Knockout
CRISPR knockout of elongation factors or their regulators is used to test whether they are required for positive regulation of translational elongation and for disease phenotypes. Loss-of-function clones can be profiled by Ribo-seq to define dependent transcripts.
Point Mutation
Point-mutation knock-in of phosphorylation sites or catalytic residues allows precise testing of signaling-dependent elongation control. This approach separates catalytic activity from scaffolding functions.
Knock-in
Tagged knock-in of elongation factors enables ribosome association and localization studies in native chromatin context. It supports proteomic and imaging readouts of GO:0045901.
Overexpression
Overexpression of candidate positive regulators can increase translational elongation and drive transformation in cell models. It is used to establish sufficiency in disease-relevant backgrounds.
How EDITGENE Supports positive regulation of translational elongation Research
Researchers studying positive regulation of translational elongation-related genes often need to determine whether a candidate gene is causally involved in controlling elongation rate, protein output or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable this causal testing in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of translational elongation research.
Frequently Asked Questions About positive regulation of translational elongation
What is positive regulation of translational elongation (GO:0045901)?
It is any process that activates or increases the frequency, rate or extent of translational elongation, the stage of protein synthesis where amino acids are added to a growing chain.
What genes are involved in positive regulation of translational elongation?
Key genes include EEF1A1, EEF2, MTOR, RPTOR, RPS6KB1, HNRNPE1, PUS7 and LINE1, among others.
How is translational elongation positively regulated?
It is stimulated by elongation factors, mTORC1 signaling, RNA-binding proteins and RNA modifications that relieve pausing and accelerate decoding.
Why is GO:0045901 important in cancer?
Enhanced elongation supports tumor biosynthetic demand, and an anaplastic prostate cancer subtype is sensitive to therapies targeting translation elongation.
What methods study positive regulation of translational elongation?
Ribo-seq, polysome profiling, puromycin incorporation, proteomics and imaging are commonly used.
Can CRISPR be used to study GO:0045901?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of elongation regulators.
What diseases are linked to translational elongation control?
Anaplastic prostate cancer, T cell exhaustion and epithelial-mesenchymal transition are linked to elongation control.
What is the difference between translation initiation and elongation?
Initiation assembles the ribosome on the mRNA, while elongation is the cyclical addition of amino acids; GO:0045901 specifically concerns positive control of elongation.
Which signaling pathway positively regulates translational elongation?
mTORC1 signaling is a major positive regulator of translational elongation.
How do I choose a model to study positive regulation of translational elongation?
Select knockout for requirement, point mutation for mechanism, knock-in for localization and overexpression for sufficiency, depending on your hypothesis.
Conclusion
GO:0045901 positive regulation of translational elongation is a central control point in gene expression that determines how fast cells build proteins. Its dysregulation contributes to cancer, immune exhaustion and EMT, making it a high-value target for mechanistic and therapeutic research. CRISPR-based cell models combined with Ribo-seq and proteomics provide a rigorous path to identify and validate the genes that positively regulate elongation.
References
- 1. Marasca F et al.. 2022. LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion.. Nat Genet 54(2):180-193 PMID: 35039641
- 4. Zou C et al.. 2024. Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation.. Sci Adv 10(14):eadm7098 PMID: 38569039
- 5. Zhao Y et al.. 2025. Pseudouridylation of 7SK by PUS7 regulates Pol II transcription elongation.. Nat Commun 16(1):9595 PMID: 41168165
- 6. Grelet S et al.. 2019. hnRNP E1 at the crossroads of translational regulation of epithelial-mesenchymal transition.. J Cancer Metastasis Treat 5 PMID: 31681852
